Accuray Incorporated (ARAY) stock rallied over 11.46% intraday to trade at $2.14 a share on NASDAQ. The stock opened with a gain of 18.89% at $2.06 and touched an intraday high of $2.15, rising 11.46% against the last close of $1.92. The stock went to a low of $2.02 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue430.82 Million
5Y Sales Change-0.10%
Fiscal Year Ends2021-06-29
IndustryHealth Care Equipment
Accuray Incorporated develops, manufactures, and sells radiotherapy systems for alternative cancer treatments in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
Accuray Incorporated (NASDAQ: ARAY) stock price is $2.14 as of the last check on Thursday, June 23. During the trading session, ARAY stock reached the peak price of $2.15 while $2.02 was the lowest point it dropped to.
The NASDAQ listed ARAY is part of Health Care Equipment industry that operates in the broader Health Care sector. Accuray Incorporated develops, manufactures, and sells radiotherapy systems for alternative cancer treatments in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney.
Mr. Joshua H. Levine
CEO & Director
Ms. Suzanne Winter M.B.A.
Mr. Patrick R. Spine
Sr. VP & Chief Admin. Officer
Mr. Jesse Chew
Sr. VP, Gen. Counsel & Corp. Sec.
ARAY stock traded closed the last session at $2.14, which is $0.22 or 11.46% lower than its previous close of $1.92. ARAY's current trading price is 25.88% lower than its 52-week high of $5.93 where as its distance from 52-week low of 1.70% is -63.91%.
Number of ARAY employees currently stands at -. ARAY operates from 1310 Chesapeake Terrace, Sunnyvale, CA 94089, United States.
Official Webiste of $ARAY is: https://www.accuray.com
ARAY stock volume for the day was 1,381,708 shares while in the previous session number of ARAY shares traded was 1,382,900 . The average number of ARAY shares traded daily for last 3 months was 981.17 Thousands.
The percentage change in ARAY stock occurred in the recent session was 11.46% while the dollar amount for the price change in ARAY stock was $0.22.
In the recent session, the day high for ARAY stock was $2.15 while the low for ARAY stock touched on the day was $2.02.
The market value of ARAY currently stands at 195.23 Million with its latest stock price at $2.14 and 92.76 Million of its shares outstanding.